QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
QQQ   422.83 (-0.14%)
TSLA   149.20 (-0.49%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)

BriaCell Therapeutics (BCTX) Earnings Date, Estimates & Call Transcripts

$2.14
-0.02 (-0.93%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jun. 12Estimated
Actual EPS
(Mar. 18)
-$0.71 Missed By -$0.51
Consensus EPS
(Mar. 18)
-$0.20
Skip Charts & View Estimated and Actual Earnings Data

BCTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BriaCell Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241($0.55)($0.55)($0.55)
Q4 20241($0.46)($0.46)($0.46)

BCTX Earnings Date and Information

BriaCell Therapeutics last announced its earnings results on March 18th, 2024. The reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.51. BriaCell Therapeutics has generated ($1.68) earnings per share over the last year (($1.68) diluted earnings per share). Earnings for BriaCell Therapeutics are expected to decrease in the coming year, from ($1.39) to ($1.40) per share. BriaCell Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 12th, 2024 based off prior year's report dates.

BriaCell Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/12/2024
Estimated)
------- 
3/18/2024Q2 2024($0.20)($0.71)($0.51)($0.71)--
12/14/2023Q4 2023($0.18)($0.50)($0.32)($0.50)--
10/25/2023Q4 2023($0.40)($0.15)+$0.25($0.15)--
6/14/2023Q3 2023($0.36)($0.32)+$0.04($0.32)--
3/15/2023Q2 2023($0.37)($0.77)($0.40)($0.77)--
12/14/2022Q1 2023($0.33)($0.07)+$0.26($0.07)--
10/27/2022Q4 2022-($1.01)($1.01)($1.01)--
6/13/2022Q3 2022($0.19)($0.32)($0.13)($0.32)--
3/15/2022Q2 2022($0.17)($0.24)($0.07)($0.24)--
12/14/2021Q1 2022-($0.15)($0.15)($0.14)--
6/29/2021Q3 2021-($0.93)($0.93)($2.44)--

BriaCell Therapeutics Earnings - Frequently Asked Questions

When is BriaCell Therapeutics's earnings date?

BriaCell Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 12th, 2024 based off last year's report dates. Learn more on BCTX's earnings history.

Did BriaCell Therapeutics beat their earnings estimates last quarter?

In the previous quarter, BriaCell Therapeutics (NASDAQ:BCTX) missed the analysts' consensus estimate of ($0.20) by $0.51 with a reported earnings per share (EPS) of ($0.71). Learn more on analysts' earnings estimate vs. BCTX's actual earnings.

How much profit does BriaCell Therapeutics generate each year?

BriaCell Therapeutics (NASDAQ:BCTX) has a recorded net income of -$20.30 million. BCTX has generated -$1.68 earnings per share over the last four quarters.

What is BriaCell Therapeutics's EPS forecast for next year?

BriaCell Therapeutics's earnings are expected to decrease from ($1.39) per share to ($1.40) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BCTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners